A secretive startup at Lilly Ventures in Indianapolis has grabbed $4.6 million of a documented $15 million round of equity financing, MedCity News reported, citing SEC documents. The recently founded Esanex doesn't appear to have a website or a publicly known research focus, but the startup does appear to have resources from drug giant Eli Lilly's ($LLY) $200 million venture unit. According to MedCity News, Lilly Ventures partner Steven Hall is identified as the young company's chief executive. Report